← Back to Analyst Consensus 
FMS Hold
Fresenius Medical Care AG
Current Price —
Implied Upside —
Analysts 29
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 12, 2026 | Truist Securities | maintain | Hold → Hold | — | 54% |
| Aug 6, 2026 | Bernstein | maintain | Market Perform → Market Perform | — | 52% |
| Sep 2, 2025 | UBS | downgrade | Neutral → Sell | $0 | 54% |
| May 12, 2025 | Truist Securities | maintain | Hold → Hold | $30 | 54% |
| Jan 6, 2025 | Truist Securities | maintain | Hold → Hold | $25 | 54% |
| Oct 7, 2024 | Truist Securities | maintain | Hold → Hold | $23 | 54% |
| Jul 31, 2024 | Truist Securities | maintain | Hold → Hold | $22 | 54% |
| May 15, 2024 | Truist Securities | maintain | Hold → Hold | $24 | 54% |
| Nov 24, 2023 | HSBC | upgrade | Reduce → Hold | $0 | 53% |
| Oct 11, 2023 | Truist Securities | maintain | Hold → Hold | $24 | 54% |
| Jul 13, 2023 | Truist Securities | maintain | Hold → Hold | $28 | 54% |
| May 10, 2023 | Truist Securities | maintain | Hold → Hold | $26 | 54% |
| Apr 13, 2023 | Truist Securities | maintain | — → Hold | $24 | 54% |
| Feb 23, 2023 | Truist Securities | maintain | — → Hold | $22 | 54% |
| Jun 22, 2022 | Truist Securities | maintain | — → Hold | $27 | 54% |
| Nov 23, 2021 | HSBC | initiate | — → Hold | $0 | 53% |
| Nov 17, 2021 | RBC Capital | maintain | — → Sector Perform | $35 | 55% |
| Nov 11, 2021 | Jefferies | upgrade | Underperform → Hold | $0 | 52% |
| May 21, 2020 | SunTrust Robinson Humphrey | maintain | — → Buy | $48 | — |
| May 11, 2020 | SunTrust Robinson Humphrey | maintain | — → Buy | $46 | — |
| Apr 13, 2020 | SunTrust Robinson Humphrey | maintain | — → Buy | $42 | — |
| Feb 21, 2020 | CFRA | upgrade | Hold → Buy | $46 | 60% |
| Jan 21, 2020 | Jefferies | upgrade | Hold → Buy | $0 | 52% |
| Oct 23, 2019 | Redburn Partners | downgrade | Buy → Neutral | $0 | — |
| Aug 1, 2019 | BTIG | downgrade | Buy → Neutral | $0 | 52% |
| Jun 20, 2019 | Barclays | upgrade | Equal-Weight → Overweight | $0 | 53% |
| Oct 26, 2018 | UBS | upgrade | Neutral → Buy | $0 | 54% |
| Oct 18, 2018 | DZ Bank | downgrade | Buy → Hold | $0 | 40% |
| Aug 28, 2018 | HSBC | upgrade | Hold → Buy | $0 | 53% |
| Apr 24, 2018 | Deutsche Bank | upgrade | Hold → Buy | $0 | 57% |
| Mar 17, 2016 | Nomura | initiate | — → Buy | $0 | — |
| Jan 5, 2016 | UBS | upgrade | Neutral → Buy | $0 | 54% |
| Oct 30, 2015 | Piper Sandler | maintain | — → Neutral | $43 | 54% |
| Oct 30, 2015 | SunTrust Robinson Humphrey | maintain | — → Buy | $54 | — |
| Aug 13, 2015 | Societe Generale | downgrade | Buy → Hold | $0 | — |
| Feb 27, 2015 | HSBC | upgrade | Underweight → Neutral | $0 | 53% |
| Dec 2, 2013 | Morgan Stanley | upgrade | Equal-Weight → Overweight | $0 | 54% |
| Jul 3, 2013 | Exane BNP Paribas | downgrade | Outperform → Neutral | $0 | 52% |
| Jun 10, 2013 | Barclays | upgrade | Equal-Weight → Overweight | $0 | 53% |
| Mar 7, 2013 | RBC Capital | downgrade | Outperform → Sector Perform | $36 | 55% |
| Nov 1, 2012 | Piper Sandler | downgrade | Overweight → Neutral | $0 | 54% |
| Jul 20, 2012 | Jefferies | downgrade | Buy → Hold | $0 | 52% |
Price Target Trend
Apr 21, 2026 Oct 26, 2026
EPS Estimates
+1q —
+1y —
0y —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days